Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Acotiamide Hydrochloride
2. N-(2-(diisopropylamino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-1,3-thiazole-4-carboxamide
3. N-(n',n'-diisopropylaminoethyl)-(2-(2-hydroxy-4,5-dimethoxybenzoylamino)-1,3-thiazole-4-yl)carboxyamide
4. Ym 443
5. Ym-443
6. Ym443 Cpd
7. Z 338
8. Z-338
1. 185106-16-5
2. Acotiamide [inn]
3. Unii-d42owk5383
4. N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxamide
5. Chembl2107723
6. Chebi:34523
7. Ym 443
8. C14127
9. D42owk5383
10. Ac1nqzwj
11. Acotiamide [mi]
12. Acotiamide [who-dd]
13. Schembl1043131
14. Dtxsid40870163
15. Hms3886o11
16. Bcp21087
17. Zinc2002237
18. Mfcd00953661
19. Mz-338
20. S5075
21. Akos025401963
22. Ccg-269239
23. Db12482
24. Sb19646
25. Ncgc00506872-01
26. Ac-27642
27. N-[2-(diisopropylamino)ethyl]-2-[(2-hydroxy-4,5-dimethoxy-benzoyl)amino]thiazole-4-carboxamide
28. Hy-121467
29. Cs-0082145
30. Acotiamide; Mz-338; Unii-d42owk5383;
31. F14756
32. A899477
33. Q4674598
34. Ym443; Ym-443; Ym 443; Z338; Z-338; Z 338
35. N-(2-(diisopropylamino)ethyl)-2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxamide
36. 4-thiazolecarboxamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-
37. N-(2-(bis(1-methylethyl)amino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)thiazol-4-carboxamide
38. N-(2-(bis(1-methylethyl)amino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)thiazole-4-carboxamide
39. N-{2-[bis(propan-2-yl)amino]ethyl}-2-(2-hydroxy-4,5-dimethoxybenzamido)-1,3-thiazole-4-carboxamide
| Molecular Weight | 450.6 g/mol |
|---|---|
| Molecular Formula | C21H30N4O5S |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 10 |
| Exact Mass | 450.19369124 g/mol |
| Monoisotopic Mass | 450.19369124 g/mol |
| Topological Polar Surface Area | 141 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 586 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of functional dyspepsia
Treatment of functional dyspepsia
Cholinesterase Inhibitors
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
ABOUT THIS PAGE
25
PharmaCompass offers a list of AC1NQZWJ API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AC1NQZWJ manufacturer or AC1NQZWJ supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AC1NQZWJ manufacturer or AC1NQZWJ supplier.
PharmaCompass also assists you with knowing the AC1NQZWJ API Price utilized in the formulation of products. AC1NQZWJ API Price is not always fixed or binding as the AC1NQZWJ Price is obtained through a variety of data sources. The AC1NQZWJ Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AC1NQZWJ manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AC1NQZWJ, including repackagers and relabelers. The FDA regulates AC1NQZWJ manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AC1NQZWJ API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AC1NQZWJ supplier is an individual or a company that provides AC1NQZWJ active pharmaceutical ingredient (API) or AC1NQZWJ finished formulations upon request. The AC1NQZWJ suppliers may include AC1NQZWJ API manufacturers, exporters, distributors and traders.
AC1NQZWJ Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AC1NQZWJ GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AC1NQZWJ GMP manufacturer or AC1NQZWJ GMP API supplier for your needs.
A AC1NQZWJ CoA (Certificate of Analysis) is a formal document that attests to AC1NQZWJ's compliance with AC1NQZWJ specifications and serves as a tool for batch-level quality control.
AC1NQZWJ CoA mostly includes findings from lab analyses of a specific batch. For each AC1NQZWJ CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AC1NQZWJ may be tested according to a variety of international standards, such as European Pharmacopoeia (AC1NQZWJ EP), AC1NQZWJ JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AC1NQZWJ USP).
